Fat targets for skeletal health
Open Access
- 26 May 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 5 (7), 365-372
- https://doi.org/10.1038/nrrheum.2009.102
Abstract
The homeostatic processes of adipogenesis and osteoblastogenesis are tightly linked, as discussed in this Review. Research into the bone–fat network has led to the elucidation of pathways that could be pharmacologically targeted in an attempt to enhance bone mass and reduce osteoporotic fracture risk. Emerging evidence points to a critical role for the skeleton in several homeostatic processes, including energy balance. The connection between fuel utilization and skeletal remodeling begins in the bone marrow with lineage allocation of mesenchymal stem cells to adipocytes or osteoblasts. Mature bone cells secrete factors that influence insulin sensitivity, and fat cells synthesize cytokines that regulate osteoblast differentiation; thus, these two pathways are closely linked. The emerging importance of the bone–fat interaction suggests that novel molecules could be used as targets to enhance bone formation and possibly prevent fractures. In this article, we discuss three pathways that could be pharmacologically targeted for the ultimate goal of enhancing bone mass and reducing osteoporotic fracture risk: the leptin, peroxisome proliferator-activated receptor gamma and osteocalcin pathways. Not surprisingly, because of the complex interactions across homeostatic networks, other pathways will probably be activated by this targeting, which could prove to be beneficial or detrimental for the organism. Hence, a more complete picture of energy utilization and skeletal remodeling will be required to bring any potential agents into the future clinical armamentarium.Keywords
This publication has 105 references indexed in Scilit:
- PPARγ2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cellsJournal of Cellular Biochemistry, 2008
- Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivoProceedings of the National Academy of Sciences of the United States of America, 2008
- The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivityThe Journal of cell biology, 2008
- The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal womenJournal of Bone and Mineral Metabolism, 2008
- Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the DuodenumCell, 2008
- TZDs and Bone: A Review of the Recent Clinical EvidencePPAR Research, 2008
- Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type miceProceedings of the National Academy of Sciences of the United States of America, 2008
- Endocrine Regulation of Energy Metabolism by the SkeletonCell, 2007
- Critical Role for Ebf1 and Ebf2 in the Adipogenic Transcriptional CascadeMolecular and Cellular Biology, 2007
- Playing with bone and fatJournal of Cellular Biochemistry, 2006